Czirr James C's Form 4/A amendment
AmendedGalectin Therapeutics Inc (GALT) · filed Dec 8, 2025
- Accession no.
- 0001493152-25-026587
- Filed
- Dec 8, 2025, 1:21 PM ET
- Trade date
- Dec 2-3, 2025
- Filing delay
- 6 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 4, 2025
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $920.9K. It was filed 6 days after the trade.
This amendment replaces 0001493152-25-026204 (filed Dec 4, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Czirr James CCIK 0001260641 | 10% Owner |
| 10X Fund, L.P.CIK 0001453356 | 10% Owner |
| 10X Capital Management, LLCCIK 0001457247 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | SSaleDisposed | −30,000 | $5.47 | −$164,100 | 5,802,207 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −132,069 | $5.73 | −$756,755.37 | 5,670,138 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.